LIFESPROUT, INC.

Profile

Company Names

LIFESPROUT, INC.

Addresses

101 W. DICKMAN ST., SUITE 900, BALTIMORE, MD 21230

1812 ASHLAND AVENUE, GROUND FLOOR, BALTIMORE, MD 21205

Phone Numbers

(410) 800-0740

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$23,895,249.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-04-06 
$21,195,249.00 
$26,195,249.00 
$5,000,000.00 
Equity 
1
2018-02-21 
$2,700,000.00 
$6,500,000.00 
$3,800,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MING 
 
FANG 
DIRECTOR
OBEN, INC.   |  LIFESPROUT, INC.   |  LYCIA THERAPEUTICS, INC.   |  AMERICAN VISION SENIOR LLC   |  GRO BIOSCIENCES INC.   |  CLEAR LABS, INC.   |  ABCURO, INC.
XIAOMING 
 
FANG 
DIRECTOR
LIFESPROUT, INC.
ERIC 
 
GOORNO 
EXECUTIVE OFFICER
BIODIRECTION, INC.   |  LIFESPROUT, INC.
ADAM 
 
GRIDLEY 
DIRECTOR, PROMOTER
HISTOGENICS CORP   |  ENTERA BIO LTD.   |  LIFESPROUT, INC.   |  ALLAY THERAPEUTICS, INC.   |  HYALEX ORTHOPAEDICS, INC.
HAI-QUAN 
 
MAO 
EXECUTIVE OFFICER, PROMOTER
LIFESPROUT, INC.
HEATHER 
 
MURREN 
DIRECTOR
LIFESPROUT, INC.
AMRIT 
 
NAGPAL 
DIRECTOR
REDMILE BIOPHARMA INVESTMENTS I, L.P.   |  REDMILE BIOPHARMA INVESTMENTS II, L.P.   |  LIFESPROUT, INC.   |  REDCO I, L.P.   |  ABSCI CORP   |  REDMILE BIOPHARMA INVESTMENTS III, L.P.   |  REDCO II, L.P.   |  REDCO II OFFSHORE FUND, L.P.   |  REDMILE GROWTH INVESTMENTS I, L.P.   |  STAR THERAPEUTICS LLC
SASHANK 
 
REDDY 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
LIFESPROUT, INC.
GREGORY 
 
SIECZKIEWICZ 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
LIFESPROUT, INC.   |  SOLAREA BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-06-29
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-06 
2020-04-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-06 
2018-03-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#